Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Changes in biological source material.

J S Robertson1

  • 1Division of Virology, National Institute for Biological Standards and Control, Blanche Lane, South Mimms, Potters Bar, Hertfordshire EN6 3QG, UK. jrobertson@nibsc.ac.uk

Biologicals : Journal of the International Association of Biological Standardization
|December 7, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Use of the nuclear reactor for neutron capture therapy of cancer.

Medical sciences (London, England)·2014
Same author

Changes in nonstructural protein 3 are associated with attenuation in avian coronavirus infectious bronchitis virus.

Virus genes·2011
Same author

Assuring the quality, safety, and efficacy of DNA vaccines.

Methods in molecular medicine·2011
Same author

Dissecting aneurysm of the aorta.

Proceedings. Royal Australasian College of Physicians·2010
Same author

Bovine serum--regulatory issues.

Developments in biologicals·2006
Same author

Viruses and assuring viral safety.

Developments in biologicals·2003
Same journal

Conformational dynamics of pneumococcal polysaccharide conjugates drive UV-vis quantification errors and a strategy to enable UV-vis spectrophotometer quantification.

Biologicals : journal of the International Association of Biological Standardization·2026
Same journal

Refining the regulatory and ethics context of controlled human infection models - a stakeholder meeting report.

Biologicals : journal of the International Association of Biological Standardization·2026
Same journal

Longevity of humoral response in recipients of rabies pre-exposure prophylactic vaccination with Abhayrab®.

Biologicals : journal of the International Association of Biological Standardization·2026
Same journal

Collaborative studies to establish WHO International Reference Reagents for diphtheria and tetanus antitoxin for use in the flocculation test.

Biologicals : journal of the International Association of Biological Standardization·2026
Same journal

Alternative approaches to phase III clinical trials for vaccine efficacy and licensure: the role of real-world evidence - a meeting report.

Biologicals : journal of the International Association of Biological Standardization·2026
Same journal

Leveraging analytical and bioprocess platforms for biological product development and commercialization - A meeting report.

Biologicals : journal of the International Association of Biological Standardization·2026
See all related articles

Changes in raw materials for biotech products, from plasma to recombinant DNA, significantly impact regulation. Subtle changes, like serum inactivation, require comparability studies to ensure product efficacy and safety.

Area of Science:

  • Biotechnology
  • Pharmaceutical Science
  • Regulatory Affairs

Background:

  • Biologics manufacturing involves sourcing raw materials, which can change over a product's lifecycle.
  • Changes can range from radical (e.g., plasma-derived to recombinant DNA) to subtle (e.g., serum inactivation).
  • Such modifications necessitate careful evaluation due to potential impacts on product quality and safety.

Purpose of the Study:

  • To analyze the regulatory and scientific implications of changes in raw materials for biotech medicinal products.
  • To highlight the importance of comparability studies following subtle manufacturing changes.
  • To emphasize a case-by-case assessment of product alterations.

Main Methods:

  • Review of regulatory consequences for different types of raw material changes.

Related Experiment Videos

  • Discussion of comparability studies to assess product alterations due to subtle changes.
  • Case-by-case evaluation framework for product efficacy and immunogenicity.

    • Main Results:

    • Radical source material changes (e.g., plasma to recombinant DNA) have major regulatory consequences.
    • Subtle changes (e.g., serum inactivation) primarily driven by viral safety needs have less severe regulatory implications.
    • Subtle changes can induce inadvertent alterations in product attributes via cell metabolism, requiring comparability assessments.

    Conclusions:

    • Manufacturing strategy drives radical changes, while viral safety concerns often drive subtle changes.
    • Comparability studies are crucial for subtle changes to address potential alterations in cell metabolism and product attributes.
    • The impact of any change on a biotech product's efficacy and immunogenicity must be assessed individually.